Nanotechnology in diagnostics and therapeutics for gastrointestinal disorders

Digestive and Liver Disease

Volumn 45, Issue 12, 2013, Pages 995-1002

  Laroui, Hamed ^a   Rakhya, Poonam ^a   Xiao, Bo ^a   Viennois, Emilie ^a,b   Merlin, Didier ^a,b  

^a GEORGIA STATE UNIVERSITY   (United States)

^b ATLANTA VA MEDICAL CENTER   (United States)

Author keywords

Diagnostics; Gastroenterology; Nanotechnology; Therapeutics

Indexed keywords

CARBON NANOTUBE; CYANOACRYLATE; DENDRIMER; FULLERENE; GOLD NANOPARTICLE; MAGNETIC NANOPARTICLE; NANOPARTICLE; NANOTUBE; NANOWIRE; POLYCAPROLACTONE; POLYETHYLENEIMINE; POLYLACTIC ACID; QUANTUM DOT;

DIAGNOSTIC VALUE; DRUG DELIVERY SYSTEM; GASTROINTESTINAL DISEASE; HUMAN; NANODEVICE; NANOPHARMACEUTICS; NANOTECHNOLOGY; NONHUMAN; PRIORITY JOURNAL; REVIEW;

DIAGNOSTICS; GASTROENTEROLOGY; NANOTECHNOLOGY; THERAPEUTICS;

COLORECTAL NEOPLASMS; DENDRIMERS; GASTROINTESTINAL DISEASES; HUMANS; INFLAMMATORY BOWEL DISEASES; LIPOSOMES; NANOMEDICINE; NANOSHELLS; NANOSTRUCTURES; NANOWIRES; QUANTUM DOTS;

EID: 84887162637     PISSN: 15908658     EISSN: 18783562     Source Type: Journal    
DOI: 10.1016/j.dld.2013.03.019     Document Type: Review

References (82)

1. Cai W.G.T., Hong H., Sun J. Applications of gold nanoparticles in cancer nanotechnology. Journal of Nanotechnology, Science and Applications 2008, 1:11.
2. Song S.Y. Future direction of nanomedicine in gastrointestinal cancer. Korean Journal of Gastroenterology 2007, 49:271-279.
3. Jabir N.R., Tabrez S., Ashraf G.M., et al. Nanotechnology-based approaches in anticancer research. International Journal of Nanomedicine 2012, 7:4391-4408.
4. A.E. World of nanobioengineering: potential big ideas for the future. In: Bloomington, editor. AuthorHouse; 2010.
5. Balasubramanian K., Burghard M. Biosensors based on carbon nanotubes. Analytical and Bioanalytical Chemistry 2006, 385:452-468.
6. Gruner G. Carbon nanotube transistors for biosensing applications. Analytical and Bioanalytical Chemistry 2006, 384:322-335.
7. Laroui H., Dalmasso G., Nguyen H.T., et al. Drug-loaded nanoparticles targeted to the colon with polysaccharide hydrogel reduce colitis in a mouse model. Gastroenterology 2010, 138. 843-53 e1-2.
8. Laroui H., Grossin L., Leonard M., et al. Hyaluronate-covered nanoparticles for the therapeutic targeting of cartilage. Biomacromolecules 2007, 8:3879-3885.
9. Laroui H., Theiss A.L., Yan Y., et al. Functional TNFalpha gene silencing mediated by polyethyleneimine/TNFalpha siRNA nanocomplexes in inflamed colon. Biomaterials 2011, 32:1218-1228.
10. Theiss A.L., Laroui H., Obertone T.S., et al. Nanoparticle-based therapeutic delivery of prohibitin to the colonic epithelial cells ameliorates acute murine colitis. Inflammatory Bowel Diseases 2011, 17:1163-1176.
11. Zhao Z.X., Gao S.Y., Wang J.C., et al. Self-assembly nanomicelles based on cationic mPEG-PLA-b-Polyarginine (R15) triblock copolymer for siRNA delivery. Biomaterials 2012, 33:6793-6807.
12. Shi S., Zhu X., Guo Q., et al. Self-assembled mPEG-PCL-g-PEI micelles for simultaneous codelivery of chemotherapeutic drugs and DNA: synthesis and characterization in vitro. International Journal of Nanomedicine 2012, 7:1749-1759.
13. Acharya G., Lee C.H., Lee Y. Optimization of cardiovascular stent against restenosis: factorial design-based statistical analysis of polymer coating conditions. PLoS ONE 2012, 7:e43100.
14. Ma X., Sim S.J. Femtomolar detection of single mismatches by discriminant analysis of DNA hybridization events using gold nanoparticles. Analyst 2013.
15. Mancuso M., Jiang L., Cesarman E., et al. Multiplexed colorimetric detection of Kaposi's sarcoma associated herpesvirus and Bartonella DNA using gold and silver nanoparticles. Nanoscale 2013, 5:1678-1686.
16. Zhu Y., Chandra P., Shim Y.B. Ultrasensitive and selective electrochemical diagnosis of breast cancer based on a hydrazine-au nanoparticle-aptamer bioconjugate. Analytical Chemistry 2013, 85:1058-1064.
17. Sensenig R., Sapir Y., MacDonald C., et al. Magnetic nanoparticle-based approaches to locally target therapy and enhance tissue regeneration in vivo. Nanomedicine (London) 2012, 7:1425-1442.
18. Hsieh W.J., Liang C.J., Chieh J.J., et al. In vivo tumor targeting and imaging with anti-vascular endothelial growth factor antibody-conjugated dextran-coated iron oxide nanoparticles. International Journal of Nanomedicine 2012, 7:2833-2842.
19. Fan Z., Senapati D., Singh A.K., et al. Theranostic magnetic core-plasmonic shell star shape nanoparticle for the isolation of targeted rare tumor cells from whole blood, fluorescence imaging, and photothermal destruction of cancer. Molecular Pharmaceutics 2012.
20. Ma Q., Nakane Y., Mori Y., et al. Multilayered, core/shell nanoprobes based on magnetic ferric oxide particles and quantum dots for multimodality imaging of breast cancer tumors. Biomaterials 2012, 33:8486-8494.
21. Poselt E., Schmidtke C., Fischer S., et al. Tailor-made quantum dot and iron oxide based contrast agents for in vitro and in vivo tumor imaging. ACS Nano 2012, 6:3346-3355.
22. Erogbogbo F., Yong K.T., Roy I., et al. In vivo targeted cancer imaging, sentinel lymph node mapping and multi-channel imaging with biocompatible silicon nanocrystals. ACS Nano 2011, 5:413-423.
23. Kambhampati S.P., Kannan R.M. Dendrimer nanoparticles for ocular drug delivery. Journal of Ocular Pharmacology and Therapeutics 2013.
24. Gras R., Relloso M., Garcia M.I., et al. The inhibition of Th17 immune response in vitro and in vivo by the carbosilane dendrimer 2G-NN16. Biomaterials 2012, 33:4002-4009.
25. Fleming C.J., Yin N.N., Riechers S.L., et al. High-resolution imaging of the intramolecular structure of indomethacin-carrying dendrimers by scanning tunneling microscopy. ACS Nano 2011, 5:1685-1692.
26. Kircher M.F., Mahmood U., King R.S., et al. A multimodal nanoparticle for preoperative magnetic resonance imaging and intraoperative optical brain tumor delineation. Cancer Research 2003, 63:8122-8125.
27. Nam J.M., Stoeva S.I., Mirkin C.A. Bio-bar-code-based DNA detection with PCR-like sensitivity. Journal of the American Chemical Society 2004, 126:5932-5933.
28. Ferrari M. Cancer nanotechnology: opportunities and challenges. Nature Reviews Cancer 2005, 5:161-171.
29. Neuwelt E.A., Varallyay P., Bago A.G., et al. Imaging of iron oxide nanoparticles by MR and light microscopy in patients with malignant brain tumours. Neuropathology and Applied Neurobiology 2004, 30:456-471.
30. Jamieson T., Bakhshi R., Petrova D., et al. Biological applications of quantum dots. Biomaterials 2007, 28:4717-4732.
31. Cai W., Chen X. Multimodality molecular imaging of tumor angiogenesis. Journal of Nuclear Medicine 2008, 49(Suppl. 2):113S-128S.
32. Madani S.Y., Naderi N., Dissanayake O., et al. A new era of cancer treatment: carbon nanotubes as drug delivery tools. International Journal of Nanomedicine 2011, 6:2963-2979.
33. Zheng G., Patolsky F., Cui Y., et al. Multiplexed electrical detection of cancer markers with nanowire sensor arrays. Nature Biotechnology 2005, 23:1294-1301.
34. Zhang G.J., Ning Y. Silicon nanowire biosensor and its applications in disease diagnostics: a review. Analytica Chimica Acta 2012, 749:1-15.
35. Etzioni R., Urban N., Ramsey S., et al. The case for early detection. Nature Reviews Cancer 2003, 3:243-252.
36. Stern E., Vacic A., Rajan N.K., et al. Label-free biomarker detection from whole blood. Nature Nanotechnology 2010, 5:138-142.
37. Sun Y.P., Fu K.F., Lin Y., et al. Functionalized carbon nanotubes: properties and applications. Accounts of Chemical Research 2002, 35:1096-1104.
38. Yue M., Lin H., Dedrick D.E., et al. A 2-D microcantilever array for multiplexed biomolecular analysis. Journal of Microelectromechanical Systems 2004, 13:290-299.
39. Majumdar A. Bioassays based on molecular nanomechanics. Disease Markers 2002, 18:167-174.
40. Alivisatos A.P. Semiconductor clusters, nanocrystals, and quantum dots. Science 1996, 271:933-937.
41. Larson D.R., Zipfel W.R., Williams R.M., et al. Water-soluble quantum dots for multiphoton fluorescence imaging in vivo. Science 2003, 300:1434-1436.
42. Gao X.H., Cui Y.Y., Levenson R.M., et al. In vivo cancer targeting and imaging with semiconductor quantum dots. Nature Biotechnology 2004, 22:969-976.
43. Navarro D.A., Bisson M.A., Aga D.S. Investigating uptake of water-dispersible CdSe/ZnS quantum dot nanoparticles by Arabidopsis thaliana plants. Journal of Hazardous Materials 2012, 211-212:427-435.
44. Yan M., Zhang Y., Xu K., et al. An in vitro study of vascular endothelial toxicity of CdTe quantum dots. Toxicology 2011, 282:94-103.
45. Chen N., He Y., Su Y., et al. The cytotoxicity of cadmium-based quantum dots. Biomaterials 2012, 33:1238-1244.
46. Akbarzadeh A., Mikaeili H., Zarghami N., et al. Preparation and in vitro evaluation of doxorubicin-loaded Fe(3)O(4) magnetic nanoparticles modified with biocompatible copolymers. International Journal of Nanomedicine 2012, 7:511-526.
47. Tang X.H., Xie P., Ding Y., et al. Synthesis, characterization, and in vitro and in vivo evaluation of a novel pectin-adriamycin conjugate. Bioorganic and Medicinal Chemistry 2010, 18:1599-1609.
48. Akbarzadeh A., Samiei M., Davaran S. Magnetic nanoparticles: preparation, physical properties, and applications in biomedicine. Nanoscale Research Letters 2012, 7:144.
49. Wang Z.M.M., Kunets V.P., Xie Y.Z.Z., et al. Multilayer self-organization of InGaAs quantum wires on GaAs surfaces. Physics Letters A 2010, 375:170-173.
50. Fortina P., Kricka L.J., Graves D.J., et al. Applications of nanoparticles to diagnostics and therapeutics in colorectal cancer. Trends in Biotechnology 2007, 25:145-152.
51. Svenson S., Tomalia D.A. Dendrimers in biomedical applications - reflections on the field. Advanced Drug Delivery Reviews 2005, 57:2106-2129.
52. Tomalia D.A., Reyna L.A., Svenson S. Dendrimers as multi-purpose nanodevices for oncology drug delivery and diagnostic imaging. Biochemical Society Transactions 2007, 35:61-67.
53. Morille M., Passirani C., Vonarbourg A., et al. Progress in developing cationic vectors for non-viral systemic gene therapy against cancer. Biomaterials 2008, 29:3477-3496.
54. Davis S.S. Biomedical applications of nanotechnology - implications for drug targeting and gene therapy. Trends in Biotechnology 1997, 15:217-224.
55. Pan B., Cui D., Sheng Y., et al. Dendrimer-modified magnetic nanoparticles enhance efficiency of gene delivery system. Cancer Research 2007, 67:8156-8163.
56. Radu D.R., Lai C.Y., Jeftinija K., et al. A polyamidoamine dendrimer-capped mesoporous silica nanosphere-based gene transfection reagent. Journal of the American Chemical Society 2004, 126:13216-13217.
57. Tang M.X., Redemann C.T., Szoka F.C. In vitro gene delivery by degraded polyamidoamine dendrimers. Bioconjugate Chemistry 1996, 7:703-714.
58. Lasic D.D., Lipowsky R., Sackmann E. Structure and dynamics of membranes. Handbook Biology Physics 1995, 493-516.
59. Lautenschläger H, editor. Liposomes. Boca Raton; 2006.
60. Martina M.S., Fortin J.P., Menager C., et al. Generation of superparamagnetic liposomes revealed as highly efficient MRI contrast agents for in vivo imaging. Journal of the American Chemical Society 2005, 127:10676-10685.
61. Lasic D.D. Novel applications of liposomes. Trends in Biotechnology 1998, 16:307-321.
62. 2 nanotube composite layers on Ti intended for biomedical applications. Journal of Biomedical Materials Research Part A 2012, 100:1954-1962.
63. Sweeney C.M., Nehl C.L., Hasan W., et al. A three-channel spectrometer for wide-field imaging of anisotropic plasmonic nanoparticles. Journal of Physical Chemistry C: Nanomaterials and Interfaces 2011, 115:15933-15937.
64. Sweeney C.M., Stender C.L., Nehl C.L., et al. Optical properties of tipless gold nanopyramids. Small 2011, 7:2032-2036.
65. Kabanov A.V., Vinogradov SV Nanogels as pharmaceutical carriers: finite networks of infinite capabilities 2009, 48:5418-5429.
66. Sasaki Y., Akiyoshi K. Nanogel engineering for new nanobiomaterials: from chaperoning engineering to biomedical applications. Chemical Record 2010, 10:366-376.
67. Tanaka T., Sato E., Hirokawa Y., et al. Critical kinetics of volume phase transition of gels. Physical Review Letters 1985, 55:2455-2458.
68. Eichenbaum G.M., Kiser P.F., Simon S.A., et al. pH and ion-triggered volume response of anionic hydrogel microspheres. Macromolecules 1998, 31:5084-5093.
69. Murthy N., Xu M., Schuck S., et al. A macromolecular delivery vehicle for protein-based vaccines: acid-degradable protein-loaded microgels. Proceedings of the National Academy of Sciences of the United States of America 2003, 100:4995-5000.
70. Hendrickson G.R., Smith M.H., South A.B., et al. Design of multiresponsive hydrogel particles and assemblies. Advanced Functional Materials 2010, 20:1697-1712.
71. Bronich T.K., Vinogradov S.V., Kabanov A.V. Interaction of nanosized copolymer networks with oppositely charged amphiphilic molecules. Nano Letters 2001, 1:535-540.
72. Merkel T.J., Jones S.W., Herlihy K.P., et al. Using mechanobiological mimicry of red blood cells to extend circulation times of hydrogel microparticles. Proceedings of the National Academy of Sciences of the United States of America 2011, 108:586-591.
73. Cheng G., Mi L., Cao Z.Q., et al. Functionalizable and Ultrastable Zwitterionic Nanogels. Langmuir 2010, 26:6883-6886.
74. Weissleder R., Kelly K., Sun E.Y., et al. Cell-specific targeting of nanoparticles by multivalent attachment of small molecules. Nature Biotechnology 2005, 23:1418-1423.
75. Kobayashi H., Kawamoto S., Brechbiel M.W., et al. Detection of lymph node involvement in hematologic malignancies using micromagnetic resonance lymphangiography with a gadolinum-labeled dendrimer nanoparticle. Neoplasia 2005, 7:984-991.
76. Kobayashi H., Kawamoto S., Sakai Y., et al. Lymphatic drainage imaging of breast cancer in mice by micro-magnetic resonance lymphangiography using a nano-size paramagnetic contrast agent. Journal of the National Cancer Institute 2004, 96:703-708.
77. Mahmood U., Weissleder R. Near-infrared optical imaging of proteases in cancer. Molecular Cancer Therapeutics 2003, 2:489-496.
78. Perez J.M., Simeone F.J., Saeki Y., et al. Viral-induced self-assembly of magnetic nanoparticles allows the detection of viral particles in biological media. Journal of the American Chemical Society 2003, 125:10192-10193.
79. Harisinghani M.G., Barentsz J., Hahn P.F., et al. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. New England Journal of Medicine 2003, 348. 2491-U5.
80. Weissleder R., Tung C.H., Mahmood U., et al. In vivo imaging of tumors with protease-activated near-infrared fluorescent probes. Nature Biotechnology 1999, 17:375-378.
81. Laroui H., Wilson D.S., Dalmasso G., et al. Nanomedicine in GI. American Journal of Physiology Gastrointestinal and Liver Physiology 2011, 300:G371-G383.
82. Laroui H., Sitaraman S.V., Merlin D. Gastrointestinal delivery of anti-inflammatory nanoparticles. Methods in Enzymology 2012, 509:101-125.